메뉴 건너뛰기




Volumn 23, Issue 5, 2014, Pages 546-551

Postoperative Tamoxifen for ductal carcinoma in situ: Cochrane systematic review and meta-analysis

Author keywords

DCIS; Ductal carcinoma in situ; Tamoxifen

Indexed keywords

ESTROGEN RECEPTOR; PLACEBO; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

EID: 84908210343     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2014.06.015     Document Type: Review
Times cited : (40)

References (15)
  • 3
    • 84891512298 scopus 로고    scopus 로고
    • Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcomes after a recurrence, from EORTC 10853 randomized phase III trial
    • Donker M., Litiere S., Werutsky G., Julien J.P., Fentiman I.S., Agresti R., et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcomes after a recurrence, from EORTC 10853 randomized phase III trial. JClin Oncol 2013, 31(32):4054-4059.
    • (2013) JClin Oncol , vol.31 , Issue.32 , pp. 4054-4059
    • Donker, M.1    Litiere, S.2    Werutsky, G.3    Julien, J.P.4    Fentiman, I.S.5    Agresti, R.6
  • 4
    • 33746408229 scopus 로고    scopus 로고
    • Comprehensive side-effect profile of anastrozole and Tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial
    • Buzdar A., Howell A., Cuzick J., Wale C., Distler W., Hoctin-Boes G., et al. Comprehensive side-effect profile of anastrozole and Tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol 2006, 7:633-643.
    • (2006) Lancet Oncol , vol.7 , pp. 633-643
    • Buzdar, A.1    Howell, A.2    Cuzick, J.3    Wale, C.4    Distler, W.5    Hoctin-Boes, G.6
  • 5
    • 29544433211 scopus 로고    scopus 로고
    • Acomparison of letrozole and Tamoxifen in postmenopausal women with early breast cancer
    • Acomparison of letrozole and Tamoxifen in postmenopausal women with early breast cancer. NEngl J Med 2005, 353:2747-2753. The Breast International Group 1-98 Collaborative Group.
    • (2005) NEngl J Med , vol.353 , pp. 2747-2753
  • 6
    • 0036230556 scopus 로고    scopus 로고
    • The molecular perspective: Tamoxifen and the estrogen receptor
    • Goodsell D.S. The molecular perspective: Tamoxifen and the estrogen receptor. Oncologist 2002, 7:163-164.
    • (2002) Oncologist , vol.7 , pp. 163-164
    • Goodsell, D.S.1
  • 7
    • 34548144485 scopus 로고    scopus 로고
    • Tamoxifen for early breast cancer
    • Tamoxifen for early breast cancer. Cochrane Database Syst Rev 2001, (1). Early Breast Cancer Trialists' Collaborative Group.
    • (2001) Cochrane Database Syst Rev , Issue.1
  • 8
    • 0345099342 scopus 로고    scopus 로고
    • Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy
    • Kerlikowske K., Molinaro A., Cha I., Ljung B.M., Ernster V.L., Stewart K., et al. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. JNatl Cancer Inst 2003, 95:1692-1702.
    • (2003) JNatl Cancer Inst , vol.95 , pp. 1692-1702
    • Kerlikowske, K.1    Molinaro, A.2    Cha, I.3    Ljung, B.M.4    Ernster, V.L.5    Stewart, K.6
  • 9
    • 0029121769 scopus 로고
    • Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy
    • Page D.L., Dupont W.D., Rogers L.W., Jensen R.A., Schuyler P.A. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995, 76:1197-2000.
    • (1995) Cancer , vol.76 , pp. 1197-2000
    • Page, D.L.1    Dupont, W.D.2    Rogers, L.W.3    Jensen, R.A.4    Schuyler, P.A.5
  • 10
    • 0035108950 scopus 로고    scopus 로고
    • Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ
    • Bijker N., Peterse J.L., Duchateau L., Robanus-Maandag E.C., Bosch C.A., Duval C., et al. Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ. Br J Cancer 2001, 84:539-544.
    • (2001) Br J Cancer , vol.84 , pp. 539-544
    • Bijker, N.1    Peterse, J.L.2    Duchateau, L.3    Robanus-Maandag, E.C.4    Bosch, C.A.5    Duval, C.6
  • 11
    • 84871874920 scopus 로고    scopus 로고
    • Postoperative Tamoxifen for ductal carcinoma in situ
    • Staley H., McCallum I., Bruce J. Postoperative Tamoxifen for ductal carcinoma in situ. Cochrane Database Syst Rev 2012, (10). Art. no.: CD007847.
    • (2012) Cochrane Database Syst Rev , Issue.10
    • Staley, H.1    McCallum, I.2    Bruce, J.3
  • 12
    • 84870403853 scopus 로고    scopus 로고
    • Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]
    • Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration. http://www.cochrane-handbook.org.
    • The Cochrane Collaboration
    • Higgins, J.P.T.1    Green, S.2
  • 13
    • 79952845819 scopus 로고    scopus 로고
    • Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS
    • Wapnir I.L., Dignam J.J., Fisher B., Mamounas E.P., Anderson S.J., Julian T.B., et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. JNatl Cancer Inst 2011, 103(6):478-488.
    • (2011) JNatl Cancer Inst , vol.103 , Issue.6 , pp. 478-488
    • Wapnir, I.L.1    Dignam, J.J.2    Fisher, B.3    Mamounas, E.P.4    Anderson, S.J.5    Julian, T.B.6
  • 14
    • 78650700810 scopus 로고    scopus 로고
    • Effect of Tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial
    • Cuzick I., Sestak S., Pinder I.O., Ellis S., Forsyth N.J., Bundred, et al. Effect of Tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol 2011, 12:21-29.
    • (2011) Lancet Oncol , vol.12 , pp. 21-29
    • Cuzick, I.1    Sestak, S.2    Pinder, I.O.3    Ellis, S.4    Forsyth, N.J.5    Bundred6
  • 15
    • 80052297510 scopus 로고    scopus 로고
    • Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: a meta-analysis of 2 randomized trials
    • Petrelli F., Barni S. Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: a meta-analysis of 2 randomized trials. Radiother Oncol 2011, 100(2):195-199.
    • (2011) Radiother Oncol , vol.100 , Issue.2 , pp. 195-199
    • Petrelli, F.1    Barni, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.